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Possible participation of nitric oxide/cyclic guanosine monophosphate/protein kinase 
C/ATP-sensitive K + channels pathway in the systemic antinociception of flavokawin B. 
 
Abstract 
The possible mechanisms of action in the antinociceptive activity induced by systemic 
administration (intraperitoneal, i.p.) of flavokawin B (FKB) were analysed using chemical 
models of nociception in mice. It was demonstrated that i.p. administration of FKB to the 
mice at 0.3, 1.0, 3.0 and 10 mg/kg produced significant dose-related reduction in the number 
of abdominal constrictions. The antinociception induced by FKB in the acetic acid test was 
significantly attenuated by i.p. pre-treatment of mice with l-arginine, the substrate for nitric 
oxide synthase or glibenclamide, the ATP-sensitive K+ channel inhibitor, but was enhanced 
by methylene blue, the non-specific guanylyl cyclase inhibitor. FKB also produced dose-
dependent inhibition of licking response caused by intraplantar injection of phorbol 12-
myristate 13-acetate, a protein kinase C activator (PKC). Together, these data indicate that 
the NO/cyclic guanosine monophosphate/PKC/ATP-sensitive K+ channel pathway possibly 
participated in the antinociceptive action induced by FKB. 
 
Keyword: Flavokawin B; Antinociceptive activity; Nitric oxide. 
 
 
